OTCMKTS:ZRSEF DocMorris (ZRSEF) Stock Price, News & Analysis $7.45 0.00 (0.00%) As of 07/27/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartHeadlinesBuy This Stock About DocMorris Stock (OTCMKTS:ZRSEF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DocMorris alerts:Sign Up Key Stats Today's Range$7.45▼$7.4550-Day Range$7.45▼$7.4552-Week Range$7.45▼$42.50VolumeN/AAverage Volume350 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview DocMorris is a leading European online pharmacy brand and a subsidiary of the Swiss-based Zur Rose Group (OTCMKTS:ZRSEF). Through its digital platform, the company offers mail-order dispensing of prescription medications and over-the-counter health products directly to consumers’ homes. The company’s core services include the online sale and delivery of prescription and non-prescription drugs, health supplements, personal care items and medical devices. Leveraging its e-commerce infrastructure and proprietary pharmacy management systems, DocMorris also provides digital health solutions such as telemedicine consultations, medication management tools and mobile app-based healthcare services. Originally launched in the early 2000s in Germany, DocMorris has expanded its reach to serve customers in multiple European countries, including the Netherlands, Belgium, Luxembourg and Switzerland. The company operates a network of licensed pharmacies and distribution centers across these regions to ensure regulatory compliance and timely deliveries. Headquartered in Cham, Switzerland, DocMorris benefits from the operational and logistical support of its parent company, Zur Rose Group, one of Europe’s largest e-pharmacy and digital health service providers. This integration enables DocMorris to continually enhance its digital offerings and expand its footprint in the rapidly evolving online healthcare market.AI Generated. May Contain Errors. Read More Receive ZRSEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocMorris and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZRSEF Stock News HeadlinesShort Interest in DocMorris AG (OTCMKTS:ZRSEF) Grows By 724.0%July 25 at 2:20 AM | americanbankingnews.comDocMorris (DOCM) Gets a Buy from JefferiesJune 5, 2026 | theglobeandmail.comThe $8,000 Gold Call Every Retirement Saver Needs to Read Right NowGold didn't creep higher—it broke $5,000, a level many analysts thought would hold. Now JPMorgan, the biggest bank on earth, just raised its 2026 gold forecast to $6,300 and laid out a credible path to $8,000 if everyday investors increase their gold allocations even slightly. Most Americans hold less than 1% in gold, and if that number moves even slightly higher, demand collides with limited supply, and prices reprice fast.July 28 at 1:00 AM | Golden Crest Metals (Ad)DocMorris AG (ZRSEF) Q1 2026 Earnings Call TranscriptApril 17, 2026 | seekingalpha.comDOCMORRIS AGMarch 27, 2026 | finanznachrichten.deDocMorris AG Charts Costly Yet Credible TurnaroundMarch 26, 2026 | tipranks.comDocMorris AG (ZRSEF) Q4 2025 Earnings Call TranscriptMarch 24, 2026 | seekingalpha.comDocMorris Overhauls Board to Strengthen Digital Health and Governance ExpertiseMarch 3, 2026 | tipranks.comSee More Headlines ZRSEF Stock Analysis - Frequently Asked Questions How have ZRSEF shares performed this year? DocMorris' stock was trading at $7.4540 at the beginning of 2026. Since then, ZRSEF stock has increased by 0.0% and is now trading at $7.4540. How do I buy shares of DocMorris? Shares of ZRSEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/28/2026Next Earnings (Estimated)8/19/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolOTCMKTS:ZRSEF CIKN/A Webwww.zurrosegroup.com Phone(152) 724-0020FaxN/AEmployees1,453Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:ZRSEF) was last updated on 7/28/2026 by MarketBeat.com Staff. From Our PartnersMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | SponsoredHow the JPMorgan $8,000 Gold Call Exposed the Biggest Mistake in Most Retirement AccountsJPMorgan has raised its 2026 gold forecast to $6,300, with a credible path to $8,000, and now calls gold a cor...Golden Crest Metals | SponsoredA 50-year dollar arrangement just ended - what it means for youIn 1974, Henry Kissinger helped create the U.S.-Saudi Arabia Joint Commission on Economic Cooperation - a litt...Golden Portfolio | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWhat Elon told his top shareholders in TexasLate last year, Elon Musk gathered top shareholders at Tesla's Texas Gigafactory to unveil a plan to double Am...Banyan Hill Publishing | SponsoredTrump’s emergency dollar resetBloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this centur...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocMorris AG Please log in to your account or sign up in order to add this asset to your watchlist. Share DocMorris With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.